CLINICAL TRIALS PROFILE FOR FIRAZYR
✉ Email this page to a colleague
All Clinical Trials for Firazyr
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00912093 ↗ | A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) | Completed | Shire | Phase 3 | 2009-07-16 | This study is being conducted to evaluate the efficacy and safety of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). |
NCT00997204 ↗ | EASSI - Evaluation of the Safety of Self-Administration With Icatibant | Completed | Jerini AG | Phase 3 | 2009-09-25 | This study is being conducted to explore the clinical safety, local tolerability, convenience and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous injections of icatibant. |
NCT00997204 ↗ | EASSI - Evaluation of the Safety of Self-Administration With Icatibant | Completed | Shire | Phase 3 | 2009-09-25 | This study is being conducted to explore the clinical safety, local tolerability, convenience and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous injections of icatibant. |
NCT01386658 ↗ | A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema | Completed | Shire | Phase 3 | 2012-01-27 | HGT-FIR-086 is a multicenter, open-label, non-randomized, single-arm study to evaluate the Pharmacokinetics, tolerability,safety, and efficacy on reproductive hormones, of a single subcutaneous (SC) administration of icatibant in approximately 30 pediatric subjects with Hereditary Angioedema (HAE) during an initial acute attack. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Firazyr
Condition Name
Condition Name for Firazyr | |
Intervention | Trials |
Hereditary Angioedema | 3 |
Hereditary Angioedema (HAE) | 2 |
ACE Inhibitor-associated Angioedema | 1 |
Angiotensin Converting Enzyme Inhibitor Induced Angioedema | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for Firazyr
Trials by Country
Clinical Trial Progress for Firazyr
Clinical Trial Phase
Clinical Trial Sponsors for Firazyr
Sponsor Name